Form D — Alveus Therapeutics, Inc.
0001231919-26-000051 · filed Jan 14, 2026
Offering
- Industry
- Pharmaceuticals
- Exemptions
- 06b
- Total offering
- $110,724,980
- Total sold
- $56,862,480
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Alveus Therapeutics, Inc.
- CIK
- 2075856
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- 2023
- Address
- 100 N. 18TH STREET, SUITE 1930
PHILADELPHIA, PA 19103 - Phone
- 215-419-7830
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Gregory Parekh · DirectorPhiladelphia, PA Find on LinkedIn ↗
-
Ivan Gergel · DirectorPhiladelphia, PA Find on LinkedIn ↗
-
Garrett Ingram · DirectorPhiladelphia, PA Find on LinkedIn ↗
-
Carlo de Notaristefani · DirectorPhiladelphia, PA Find on LinkedIn ↗
-
Ameet Nathwani · DirectorPhiladelphia, PA Find on LinkedIn ↗
-
Raj Kannan · Executive OfficerPhiladelphia, PA Find on LinkedIn ↗
-
Jan Van de Bossche · DirectorPhiladelphia, PA Find on LinkedIn ↗
-
Claudio Nessi · DirectorPhiladelphia, PA Find on LinkedIn ↗
View the original filing on SEC EDGAR ↗